Cancer Vaccine Week articles from May 2009

Cancer Vaccine Week archives from May 2009

Researchers from University of Georgia report details of new studies and findings in the area of cancer vaccines.
May 4, 2009... "Epithelial cancer cells often overexpress mucins that are aberrantly glycosyloted. Although it has been realized that these compounds offer exciting opportunities for the development of immunotherapy for cancer, their use is hampered by the...

Study results from S.U. Ahmed and colleagues broaden understanding of cancer vaccines.(Report)
May 4, 2009... According to recent research from the United States, "Background aims Chronic lymphocytic leukemia (CLL) is an indolent disease. It is currently recommended that patients with CLL stages 0 and I follow a watchful waiting strategy." "These...

Investigators at Johns Hopkins University, Medical Department release new data on life sciences.
May 4, 2009... According to a study from the United States, "Immune evasion is an important reason why the immune system cannot control tumor growth. To elucidate the mechanism for tumor immune evasion, we generated an immune-resistant human papillomavirus...

World Vaccines Market 2008-2013 Future Forecast, Critical Trends and Developments.(Industry overview)
May 4, 2009... Research and Markets (http://www.researchandmarkets.com/research/bd84fc/world_vaccines_mar) has announced the addition of the "World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments" report to their offering. World...

Researchers from Ludwig-Maximilians University, Department of Internal Medicine describe findings in cancer vaccines.
May 4, 2009... Current study results from the report, 'Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo,' have been published. "Dendritic cell (DC) vaccines have emerged as a promising...

Researchers at Dana-Farber Cancer Institute release new data on vaccines.
May 4, 2009... A new study, 'ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization,' is now available. "Vaccine research is a combinatorial science requiring computational...

Advaxis in Drug Licensing Discussions for Its Flagship Vaccine Construct, ADXS11-001.
May 4, 2009... Advaxis, Inc. (OTCBB: ADXS) is in drug licensing discussions for its flagship vaccine construct, ADXS11-001(formerly named Lovaxin-C), in non-US markets (see also Advaxis, Inc). Due to the potential materiality of the aforementioned event,...

Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer.
May 4, 2009... Researchers from Dendreon Corporation (NASDAQ:DNDN) presented today data from its PROTECT (PROvenge Treatment and Early Cancer Treatment) or P-11 Phase 3 study suggesting that PROVENGE(R) (sipuleucel-T) induces long-term memory immune responses...

ERYtech Pharma Presents Very Encouraging Results of Its R&D Platform at the AACR in Denver.
May 4, 2009... ERYtech Pharma will present very encouraging results of its R&D platform at the annual meeting of the American Association of Cancer Research at the Colorado Convention Center in Denver (CO) between 18th to 21th April (see also ERYtech Pharma)....

Microparticle immune response modifier shows broad effects against recurrent or metastatic cancer.
May 4, 2009... MIS416, a novel microparticle-based immune response modifier, demonstrated the ability to significantly reduce the number and size of metastatic tumors in preclinical mouse models of lung and breast cancers, Innate Therapeutics (formerly...

Advaxis Applies for Approximately $1.0 Million Worth of Grants from the National Institute of Health.
May 11, 2009... Advaxis, Inc. (OTCBB: ADXS) has met the needed application requirements for approximately $1.0 million worth of grants from the National Institute of Health (NIH) in the development of its Listeria monocytogenes platform (see also Advaxis,...

Researchers from Musashino University report on findings in angiogenesis.
May 11, 2009... "Key role of angiogenesis in tumor growth and metastasis based on accumulating evidence and recent progress of immunotherapy have led us to investigate vaccine therapy targeting tumor angiogenesis. C57BL/6J mice were vaccinated with a syngeneic...

New cancer vaccines research has been reported by J.L. Zhu et al.
May 11, 2009... According to recent research from the United States, "Carbohydrate and peptide-based antitumor vaccine constructs featuring clusters of both tumor associated carbohydrate antigens and mucin-like peptide epitopes have been designed, synthesized,...

New cancer vaccines study findings reported from University of Pittsburgh.
May 11, 2009... According to recent research from the United States, "Dendritic cells (DC) loaded with tumor antigens from apoptotic/necrotic tumor cells are commonly used as vaccines for cancer therapy. However, the use of dead tumor cells may cause both...

Reports from National Institutes of Health describe recent advances in cancer vaccines.
May 11, 2009... "The sperm-derived SPANX family proteins can be found expressed in human tumors. Here, we aimed to perform a comprehensive study to evaluate immunotherapeutic relevance of one of its members, SPANX-B," scientists in the United States report...

LA BioMed Investigator Elected President of the International Society of Andrology.
May 11, 2009... At the 9th International Congress of Andrology in Barcelona, the International Society of Andrology chose as its new president Christina Wang, MD, a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)...

Dendreon Corp. (Nasdaq: DNDN) - Prostate Cancer Patients Benefit.(Report)
May 11, 2009... Less than two weeks ago, early on April 15th, Stock Preacher, in their Stock Talk section, posted a Special Technical Report on Dendreon Corporation (NASDAQ:DNDN), which we have been watching since 2007, when we first learned about it (see also...

Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections.
May 11, 2009... Royer Animal Health, LLC, a wholly owned subsidiary of Royer Biomedical, Inc., has executed an exclusive distribution agreement with MWI Veterinary, Supply, Inc. (NASDAQ:MWIV) to market its lead animal health products: MATRIX III CISPLATIN...

Two UCLA Neurosurgeons to Be Showcased in Documentary for the First Official National Brain Tumor Awareness Month.
May 11, 2009... Two of UCLA's neurosurgeons will be featured in the Nation's first official Brain Tumor Awareness Month. Dr. Linda Liau, Professor of neurosurgery and Dr. John Frazee, a cutting-edge neurosurgeon, will show their skills as they perform surgery...

Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer.(Industry overview)(Report)
May 11, 2009... Research and Markets (http://www.researchandmarkets.com/research/0c996d/dealmaking_and_ind) has announced the addition of Decision Resources, Inc.'s new report "Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer"...

Sickle Cell Treatment Developed at LA BioMed Approved for Phase 3 Clinical Trial.
May 11, 2009... The Food and Drug Administration (FDA) gave its approval for Emmaus Medical, Inc. to begin a Phase 3 clinical trial of an experimental treatment for sickle cell disease (see also Sickle Cell Anemia). The patented experimental treatment was...

Findings from H.Y. Cui et al in artificial chromosomes reported.
May 18, 2009... According to recent research published in the Journal of Virological Methods, "Marek's disease virus (MDV) is a highly oncogenic alphaherpesvirus that induces rapid-onset T-cell lymphoma in poultry. The complete genome of the avirulent vaccine...

Studies from J. Grunewald and co-researchers update current data on cancer vaccines.
May 18, 2009... "For more than 2 centuries active immunotherapy has been at the forefront of efforts to prevent infectious disease [Waldmann TA (2003) Nat Med 9: 269-277]. However, the decreased ability of the immune system to mount a robust immune response to...

New findings reported from D. Simatherai and co-authors describe advances in human papillomavirus vaccines.(Report)
May 18, 2009... According to recent research published in the journal Sexually Transmitted Infections, "This study aimed to ascertain the attitudes of men who have sex with men (MSM) to the human papillomavirus (HPV) vaccine and to determine the age at which...

Research from M. Popkov and co-researchers in the area of melanoma described.
May 18, 2009... "The ability to instantly create a state of immunity as achieved in the passive transfer of hyperimmune globulin has had a tremendous impact on public health. Unlike passive immunization, active immunization, which is the foundation of...

Bioniche Reports Fiscal 2009 Third Quarter.(Financial report)
May 18, 2009... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, announced financial results for the third quarter of its 2009 fiscal year, ending March 31, 2009 (see also Bioniche Life Sciences...

6 Top Stars From Acting, Music and Politics Go Home With You for Mother's Day.
May 18, 2009... If it takes irreverence to get noticed, the Men for Women Now initiative is doing just that. "Using humor in the same sentence as mammogram and pap smear may be a little unorthodox, but if that's what it takes to get the women in your life to...

Early Detection of Melanoma Plus Regular Skin Exams is Vital for Beating Disease.
May 18, 2009... On television's popular "Grey's Anatomy," Dr. Izzie Stevens faces a grim diagnosis: stage IV metastatic melanoma. As the drama unfolds, viewers get a glimpse at why patients with the deadliest form of skin cancer -- in the most advanced stage...

Personalized treatment for early lung cancer.
May 18, 2009... Cancer vaccines and targeted therapies are beginning to offer new treatment options following surgery for patients with early stages of lung cancer, experts said at the first European Multidisciplinary Conference in Thoracic Oncology (EMCTO) in...

Global Health Efforts Make Progress Against Child Deaths.
May 18, 2009... Recent initiatives in global health have made significant advances in knowledge, prevention and reduction of diseases affecting children in low-income countries (see also Pediatrics). Those advances will be the subject of discussion on...